Hypoglycemia: While GLP-1 medications themselves rarely cause hypoglycemia (low blood sugar) when used as monotherapy, combining them with a mechanism of action that causes hypoglycemia such as insulin or sulfonylureas can increase the risk of hypoglycemia
It depends on your health needs and goals whether or not a GLP-1 supplement is appropriate for you
Abstract Purpose of Review This review explores the rationale and available evidence behind incretin-based therapies for metabolic dysfunction-associated steatotic disease (MASLD) and metabolic-associated steatohepatitis (MASH), focusing on glucagon-like peptide 1 (GLP-1) and glucagon (GCG) receptor dual agonists (GLP-1/GCG RAs)
Comparing percentages from separate trials can be misleading because trial populations and methods differ
These new treatment options arent just about numbers on a scale theyre about restoring confidence, improving overall health, and giving Miami women with PCOS a renewed sense of control over their bodies and their lives.
Studies show that a 15-minute walk after meals can reduce intestinal transit time by up to 30%